Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ØJENKLINIKKEN SPECIALLÆGE KIM KAMP BØRME ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   2.5% 1.4% 1.4% 1.0% 2.3% 1.9% 10.1% 9.9%   Credit score (0-100)   64 80 79 85 64 68 24 25   Credit rating   BBB A A A BBB A BB BB   Credit limit (kDKK)   0.0 16.4 24.4 194.1 0.1 1.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,205 2,295 2,504 2,701 2,347 947 0.0 0.0   EBITDA   174 396 568 995 2,178 558 0.0 0.0   EBIT   121 325 495 936 2,159 539 0.0 0.0   Pre-tax profit (PTP)   116.3 319.5 499.2 1,039.4 1,943.8 726.3 0.0 0.0   Net earnings   89.8 248.1 388.1 808.3 1,512.0 564.3 0.0 0.0   Pre-tax profit without non-rec. items   116 319 499 1,039 1,944 726 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   77.2 245 195 136 30.5 11.6 0.0 0.0   Shareholders equity total   852 1,046 1,379 2,131 3,529 3,975 1,725 1,725   Interest-bearing liabilities   103 107 111 115 108 100 0.0 0.0   Balance sheet total (assets)   1,263 1,517 2,128 2,896 4,373 4,668 1,725 1,725   Net Debt   -643 -717 -1,367 -2,208 -1,994 -2,646 -1,725 -1,725     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,205 2,295 2,504 2,701 2,347 947 0.0 0.0   Gross profit growth   -10.9% 4.1% 9.1% 7.9% -13.1% -59.7% -100.0% 0.0%   Employees   3 3 3 3 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -66.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,263 1,517 2,128 2,896 4,373 4,668 1,725 1,725   Balance sheet change%   -2.8% 20.1% 40.2% 36.1% 51.0% 6.7% -63.0% 0.0%   Added value   174.0 396.0 568.1 995.1 2,217.8 557.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -107 97 -123 -118 -124 -38 -12 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.5% 14.2% 19.8% 34.7% 92.0% 56.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.4% 23.4% 27.8% 42.1% 59.4% 16.3% 0.0% 0.0%   ROI %   12.9% 30.9% 38.4% 56.6% 73.5% 19.1% 0.0% 0.0%   ROE %   10.8% 26.1% 32.0% 46.1% 53.4% 15.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   67.5% 69.0% 64.8% 73.6% 80.7% 85.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -369.6% -181.0% -240.7% -221.9% -91.6% -474.5% 0.0% 0.0%   Gearing %   12.1% 10.2% 8.0% 5.4% 3.1% 2.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.1% 5.5% 7.6% 15.1% 194.3% 11.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.5 2.4 2.4 3.4 5.1 6.7 0.0 0.0   Current Ratio   2.5 2.4 2.4 3.4 5.1 6.7 0.0 0.0   Cash and cash equivalent   746.1 823.3 1,478.1 2,323.2 2,101.9 2,745.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   632.2 653.9 619.8 555.7 2,108.3 1,774.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   58 132 189 332 2,218 558 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   58 132 189 332 2,178 558 0 0   EBIT / employee   40 108 165 312 2,159 539 0 0   Net earnings / employee   30 83 129 269 1,512 564 0 0